Kirksville College of Osteopathic Medicine
Apply to ATSU Now
KCOM Student

Faculty and Staff

Scholarly Activity Home | List of Authors | Publications | Presentations & Abstracts
Professional Presentations e.g., CME | Grants Funded | Honors & Recognition

Publications of Deborah A. Hudman, M.S.

   
12.
Lee MC, Franco M, Vargas DM, Hudman DA, White SJ, Fowler RG, Sargentini NJ. A ΔdinB mutation that sensitizes Escherichia coli to the lethal effects of UV- and X-radiation. Mutat Res. 2014 Mar 20;763-764C:19-27. doi:10.1016/j.mrfmmm. 2014.03.003. [Epub ahead of print] PubMed
11.

Resazurin-based assay for screening bacteria for radiation sensitivity. Springerplus. 2013; 2(1):55. Epub 2013 Feb 16. Hudman DA, Sargentini NJ. PubMed

10.
Borisevich V, Nistler R, Hudman D, Yamshchikov G, Seregin A, Yamshchikov V. A highly sensitive and versatile virus titration assay in the 96-well microplate format. J Virol Methods. 2008 Feb;147(2):197-205. PubMed
9.

Pereboev A, Borisevich V, Tsuladze G, Shakhmatov M, Hudman D, Kazachinskaia E, Razumov I, Svyatchenko V, Loktev V, Yamshchikov V. Genetically delivered antibody protects against West Nile virus. Antiviral Res. 2008 Jan;77(1):6-13. Epub 2007 Sep 14. PubMed

  Earlier publications refer to DA Whitaker instead of DA Hudman
8.
Keating FK, Dauerman HL, Whitaker DA, Sobel BE, Schneider DJ. Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin. Thromb Res. 2006;118(3):361-9. Epub 2005 Sep 1.   PubMed
7.

Schneider DJ, Keating FK, Baumann PQ, Whitaker DA, Sobel BE. Increased ability of tirofiban to maintain its inhibitory effects on the binding of fibrinogen to platelets in blood from patients with and without diabetes mellitus. Coron Artery Dis. 2006 Feb;17(1):57-61. PubMed

6.
Keating FK, Dauerman HL, Whitaker DA, Sobel BE, Schneider DJ. The effects of bivalirudin compared with those of unfractionated heparin plus eptifibatide on inflammation and thrombin generation and activity during coronary intervention. Coron Artery Dis. 2005 Sep;16(6):401-5. PubMed
5.
Schneider DJ, Baumann PQ, Whitaker DA, Sobel BE. Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen. J Cardiovasc Pharmacol. 2005 Jul;46(1):41-5. PubMed
4.

Keating FK, Whitaker DA, Kabbani SS, Ricci MA, Sobel BE, Schneider DJ. Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis. Am J Cardiol. 2004 Sep 15;94(6):725-8. PubMed

3.
Keating FK, Whitaker DA, Sobel BE, Schneider DJ. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes. Thromb Res. 2004;113(1):27-34. PubMed
2.
Schneider DJ, Whitaker DA, Sobel BE. Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions. Coron Artery Dis. 2004 May;15(3):177-81. PubMed
1.
Aggarwal A, Whitaker DA, Rimmer JM, Solomon RJ, Gennari FJ, Sobel BE, Schneider DJ. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis. Nephrol Dial Transplant. 2004 Jun;19(6):1559-63. Epub 2004 Mar 19. PubMed